- Home
- LAES vs BNTC Comparison
LAES vs BNTC Comparison
Compare LAES & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- BNTC
- Stock Information
- Founded
- LAES 2022
- BNTC 1995
- Country
- LAES Switzerland
- BNTC United States
- Employees
- LAES N/A
- BNTC N/A
- Industry
- LAES Semiconductors
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- BNTC Health Care
- Exchange
- LAES Nasdaq
- BNTC Nasdaq
- Market Cap
- LAES 307.1M
- BNTC 339.8M
- IPO Year
- LAES N/A
- BNTC N/A
- Fundamental
- Price
- LAES $3.32
- BNTC $14.97
- Analyst Decision
- LAES Strong Buy
- BNTC Strong Buy
- Analyst Count
- LAES 1
- BNTC 7
- Target Price
- LAES $6.00
- BNTC $24.43
- AVG Volume (30 Days)
- LAES 13.7M
- BNTC 33.7K
- Earning Date
- LAES 03-24-2025
- BNTC 05-12-2025
- Dividend Yield
- LAES N/A
- BNTC N/A
- EPS Growth
- LAES N/A
- BNTC N/A
- EPS
- LAES N/A
- BNTC N/A
- Revenue
- LAES $20,135,000.00
- BNTC N/A
- Revenue This Year
- LAES N/A
- BNTC N/A
- Revenue Next Year
- LAES N/A
- BNTC N/A
- P/E Ratio
- LAES N/A
- BNTC N/A
- Revenue Growth
- LAES N/A
- BNTC N/A
- 52 Week Low
- LAES $0.29
- BNTC $4.75
- 52 Week High
- LAES $11.00
- BNTC $15.29
- Technical
- Relative Strength Index (RSI)
- LAES 52.81
- BNTC 70.53
- Support Level
- LAES $2.40
- BNTC $11.99
- Resistance Level
- LAES $2.94
- BNTC $13.00
- Average True Range (ATR)
- LAES 0.39
- BNTC 1.03
- MACD
- LAES 0.07
- BNTC 0.34
- Stochastic Oscillator
- LAES 95.00
- BNTC 94.17
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.